Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) Peptide
CHRNA9
Reactivité: Humain, Poulet
Hôte: Synthetic
BP
-
- Antigène Tous les produits CHRNA9
- CHRNA9 (Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9))
- Origine
- Humain, Poulet
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Attributs du produit
- The peptide is used to block Anti-CHRNA9 Antibody reactivity.
-
-
- Indications d'application
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Buffer
- Lyophilized powder
- Stock
- -20 °C
- Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year.
- Date de péremption
- 12 months
-
- Antigène
- CHRNA9 (Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9))
- Synonymes
- HSA243342 Peptide, NACHRA9 Peptide, 2410015I05Rik Peptide, Acra9 Peptide, EG666827 Peptide, Gm8311 Peptide, cholinergic receptor nicotinic alpha 9 subunit Peptide, cholinergic receptor, nicotinic, alpha polypeptide 9 Peptide, CHRNA9 Peptide, Chrna9 Peptide
- Sujet
- NACHRA9, Neuronal acetylcholine receptor subunit alpha-9, Nicotinic acetylcholine receptor subunit alpha-9, NACHR alpha-9
- ID gène
- 55584
- UniProt
- Q9UGM1
-
Vous êtes ici:
